1035690-24-4 Usage
Description
2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is a boronic ester chemical compound with the molecular formula C13H19BO2. It is characterized by its unique structure and ability to form stable boronate complexes with diols and other nucleophiles, which makes it a valuable reagent in organic synthesis, especially in the pharmaceutical industry.
Uses
Used in Organic Synthesis:
2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is used as a reagent in organic synthesis for its ability to form stable boronate complexes with diols and other nucleophiles. This property is crucial in the formation of carbon-carbon and carbon-heteroatom bonds, facilitating the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is used as a key intermediate in the synthesis of various drugs and bioactive compounds. Its unique structure and reactivity make it a versatile building block for the development of new pharmaceutical agents.
Used in Medicinal Chemistry Research:
2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is also utilized as a tool in medicinal chemistry research. Its ability to form stable boronate complexes allows researchers to explore new chemical reactions and pathways, leading to the discovery of novel bioactive compounds and potential drug candidates.
Used in the Synthesis of Complex Natural Products:
2-(3-Cydopropoxy-phenyl)-4,4,5,5-tetraMethy-[1,3,2]dioxaborolane is used as an intermediate in the synthesis of complex natural products, which often possess significant biological activities. The unique reactivity of 2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane enables the efficient construction of intricate molecular frameworks, facilitating the development of new natural product-inspired therapeutic agents.
Used in the Preparation of Functionalized Materials:
Due to its versatile structure, 2-(3-Cyclopropoxy-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane is employed in the preparation of various functionalized materials. Its ability to form stable boronate complexes with different nucleophiles allows for the development of materials with tailored properties, such as improved stability, reactivity, or selectivity, which can be applied in various fields, including catalysis, sensors, and advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1035690-24-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,6,9 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1035690-24:
(9*1)+(8*0)+(7*3)+(6*5)+(5*6)+(4*9)+(3*0)+(2*2)+(1*4)=134
134 % 10 = 4
So 1035690-24-4 is a valid CAS Registry Number.
1035690-24-4Relevant articles and documents
GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 00567; 00569; 001389; 001390, (2021/01/22)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 00609; 00610; 00612; 001431; 001432; 001433, (2019/07/17)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
CONFORMATIONALLY CONSTRAINED CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS
-
, (2009/10/22)
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I or the general formula III: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
